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Immunity to gastrointestinal nematode infections
D Sorobetea1, M Svensson-Frej1,2 and R Grencis3
Numerous species of nematodes have evolved to inhabit the gastrointestinal tract of animals and humans, with over a
billion of the world’s population infected with at least one species. These large multicellular pathogens present a
considerable and complex challenge to the host immune system given that individuals are continually exposed to
infective stages, as well as the high prevalence in endemic areas. This review summarizes our current understanding of
host–parasite interactions, detailing induction of protective immunity, mechanisms of resistance, and resolution of the
response. It is clear from studies of well-defined laboratory model systems that these responses are dominated by
innate and adaptive type 2 cytokine responses, regulating cellular and soluble effectors that serve to disrupt the niche in
which the parasites live by strengthening the physical mucosal barrier and ultimately promoting tissue repair.
HELMINTHS AND HUMANS
Nature is rife with parasitism, and it has been estimated that one
fifth of all humans are hosting one or more species of
gastrointestinal nematode.1 As with many other pathogens,
parasitic worm infections are prevalent among children in
developing countries where hygienic conditions are poor, with
symptoms ranging from abdominal pain and mild anemia to
diarrhea, stunted growth, and impaired cognitive development;
a tragedy given that most nematodes are easily avoided by
improvements in basic hygiene, such as access to clean drinking
water. Efforts to treat infected individuals with antihelminthic
drugs are thus rendered relatively ineffective in the long term
because of continued exposure to infective eggs and larvae in
the immediate environment, frequently resulting in reinfection.
With that being said, some parasites might incur benefits as
well. Epidemiological data demonstrate that over the past
decades there has been a steady rise in both the prevalence and
incidence of various immune-associated disorders,2–4 whereas
the occurrence of parasite infections has decreased dramati-
cally.5 This inverse correlation has given rise to the hygiene
hypothesis that, as the name implies, proposes that excessive
cleanliness alters the balance of the immune system (in part
because of the lack of parasite exposure), thus resulting in
aberrant reactions to harmless environmental molecules, food
antigens, or the body itself. Given that our species evolved in
close contact with a diverse array of pathogens, this explanation
is certainly plausible,6,7 so much so that some have considered
using worm infections as treatment, notably for inflammatory
bowel disease.8,9 Regardless, it is clear that parasites have had,
and will continue to have, a significant impact on our species in
the foreseeable future. Hence, understanding the complex
interaction between gastrointestinal parasites and the mucosal
immune system is of crucial importance, not just for the
development of improved antihelminthic therapies, but also for
potential treatments targeting inflammatory and autoimmune
disorders.
Herewe describe the cellular andmolecularmechanisms that
promote protective immunity to enteric roundworm infection.
Much of our current understanding comes from wild rodent
parasites that have been adopted for laboratory use, including
Heligmosomoides polygyrus,10 Nippostrongylus brasiliensis,11
Trichinella spiralis,12 and Trichuris muris,13 that closely mimic
human helminth infections. Although the life cycles of these
nematodes vary greatly, a crucial part of their lifespans is spent
in the intestinal tract where a distinct form of protective
immunity is elicited, namely type 2 immunity.
TYPE 2 IMMUNITY
Nematode infections are fundamentally different from other
pathogen encounters. Whereas the average bacterium is
B2 mm in length, adult worms can be several hundred times
larger than the typical immune cell. As a consequence, the
essential physiological and immunological mechanisms
required for the expulsion of parasitic worms are altogether
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different from those elicited in response to bacterial, fungal, or
viral infections. The type 2 response entails several biological
processes that serve to disrupt the parasite niche by strength-
ening the physical barrier and promoting tissue repair. These
mechanisms are highly coordinated and involve several
different cell types and effector molecules that have been
implicated at various stages of the response (Figure 1).
DETECTION
Although the early events after gastrointestinal nematode
infection are poorly understood, epithelial cells are clearly the
first host cells to come in contact with parasite larvae once the
mucus barrier has been breached (Figure 1a). Whether or not
these cells survive the assault and are capable of responding to
infection is unknown. Alternatively, healthy epithelial cells
adjacent to infected ones might sense secreted parasite-derived
molecules and/or tissue-derived damage-associated molecules
to initiate the inflammatory cascade. Regardless, mice in which
nuclear factor-kB signaling is abrogated specifically in
epithelial cells are incapable of generating protective
immunity upon T. muris infection and thus cannot expel
the worms,14 strongly indicating that there is need for epithelial
activation before immune engagement. Indeed, recent evidence
from H. polygyrus, N. brasiliensis, and T. spiralis infections
demonstrates that specialized chemosensory epithelial cells
called tuft cells expand upon infection and are critical for
providing the early signals that drive type 2 immunity.15–17 It is
unclear whether the larvae are sensed directly by tuft cells or
indirectly via signals from other epithelial cell subsets before
activation. Nevertheless, mice that lack intestinal tuft cells do
not expel N. brasiliensis,15 thus implicating the epithelium in
the generation of protective immunity.
The precise parasite-derived antigens being recognized by
epithelial cells are largely unknown. A possible candidate is the
polysaccharide chitin; one of the main components of the
nematode egg, and expressed in the secretory apparatus of
larvae and during molting. Chitin elicits strong type 2
immunity in the lung mucosa,18,19 and acidic mammalian
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Figure 1 Immunity to gastrointestinal nematode infections. (a) Detection and transmission phase in the intestinal tissue. (b) Induction of immunity in the
draining lymphoid tissue. (c) Expulsion of the parasites from the intestine and resolution of the response.
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chitinase, which is predominantly expressed by certain
pulmonary20 and gastrointestinal21 epithelial cells, is required
for optimal protection against both N. brasiliensis and H.
polygyrus infections.22 However, as chitin is also amajor part of
the fungal cell wall, it alone is an insufficient explanation for the
induction of antiparasitic immunity. Given that intestinal
nematodes tend to cause more tissue destruction than other
pathogens (because of their sheer size and invasiveness), it is
perhaps more plausible that type 2 immunity results from
combined recognition of both endogenous damage-associated
alarmins and worm-derived molecules that become available
for uptake after larval molting (including chitin), as well as
parasite-derived antigens that are continuously secreted
throughout infection. Cholinergic neurons, which innervate
the mucosal tissue, were recently shown to promote type 2
immunity in response to secreted products from N. brasi-
liensis,23 lending credence to this hypothesis. However, the
exact mechanisms of detection remain to be elucidated.
TRANSMISSION
Once a parasite has been detected by the epithelium and/or other
nonhematopoietic cells, the signal is transmitted to cells of the
innate immune system so that an appropriate inflammatory
cascade can be initiated (Figure 1a).Whereas neurons relay their
signals via the neurotransmitter neuromedin U,23,24 the main
epithelial-derived cytokines implicated in the early generation of
type 2 immunity are interleukin (IL)-25,25–28 IL-33,29–31 and
thymic stromal lymphopoietin (TSLP)14,32,33 that strongly
synergize and prompt the release of IL-4, IL-5, IL-9, and
IL-13 from various sources, notably type 2 innate lymphoid cells
(ILC2).15–17,25,34–38 Epithelium-derived IL-25 and IL-33, in
particular, are important for driving IL-5 and IL-13 production
from ILC2, the latter of which induces a number of responses,
including goblet and tuft cell expansion, resulting in a strong
positive feedback loop with increased production of IL-25 by
epithelial cells.15–17,31,34–37 As a consequence, mice lacking IL-25
have less efficient expulsion of T. muris,26 T. spiralis,39
N. brasiliensis,25,27,40 and H. polygyrus28 worms. Furthermore,
exogenous administration of IL-25 fails to restore expulsion in
il13 / mice,25,27 whereas the reverse is true,15,17 illustrating
that IL-25 acts upstream of IL-13 rather than directly on
expulsion. Strikingly, exogenous administration of IL-25 in the
early stages ofN. brasiliensis infection results in worm clearance
in both wild-type and rag1–/– mice,25 strongly suggesting that at
high enough concentrations of IL-25, ILC2 activation can
overcome T- and B-cell deficiency (which normally is associated
with chronicity). It should also be noted that although epithelial
tuft cells appear to be the main producers of IL-25 in mice,15,17
human eosinophils and basophils are capable of secreting
this cytokine as well.41 Nevertheless, mice that lack the
IL-25-regulating protein Act1 specifically in epithelial cells
cannot expel N. brasiliensis,42 further emphasizing the impor-
tance of epithelial-derived IL-25 in mediating type 2 immunity.
Whereas IL-25 is predominantly tuft cell derived, IL-33 is
expressed by several epithelial cell subsets,17 as well as some
hematopoietic cell types.43,44 It belongs to the IL-1 family of
cytokines and is thus translated in a proform that can be further
processed. However, in contrast to IL-1b and IL-18, IL-33 is
biologically active before cleavage and can localize to the
nucleus where it binds chromatin, which is augmented upon T.
spiralis infection.45 Its precise role is unclear46 but it appears to
be inactivated rather than activated upon cleavage by caspase-1,47
thus preventing its function as an epithelial-derived alarmin
undernormal conditions. In contrast, once IL-33 is released in the
setting of tissue damage, it can be further activated by
granulocyte-derived proteases to exert its function.48,49 Much
like IL-25, it is important for driving IL-13 production by ILC2
during infection31,35 and can also be recognized by other cell
types.50–53 Furthermore, whereas exogenous administration of
IL-33 at early time points afterT.muris infection promotes worm
clearance, injection at later stages of infection does not induce
expulsion,29 suggesting that there is an early window of
opportunity in which it exerts its effects. The relative importance
of IL-33 as compared with IL-25 is not clear, as there is some
functional redundancy between the two, and it thus remains to
be determined whether both are equally important upon parasite
infection.
Another function of IL-33 is to induce the expression of
TSLP in the epithelium.29 The data on TSLP during parasite
infections are sparse, but unlike IL-25 and IL-33, which are
critical for the expulsion of multiple parasites, TSLP appears to
be involved only during T. muris but not N. brasiliensis or H.
polygyrus infections,14,32,33 and this is understandable given
that TSLP is mainly expressed in the large intestine.33 TSLP can
be directly recognized by dendritic cells54 as well as basophils,55
again suggesting that epithelial-derived cytokines can bypass
ILC2. Indeed, although the main target of IL-25, IL-33, and
TSLP appear to be ILC2, it should be noted that both murine
and humanmemory T cells are strongly activated by IL-25,41,53
IL-33,53,56,57 and TSLP,53,58 without the need for T-cell receptor
engagement,57,59 thus being able to respond to antigen
nonspecifically. Hence, it remains to be determined what
the target cells are for these cytokines, and whether ILCs are
truly critical for antiparasitic immunity in previously chal-
lenged hosts.
In contrast to epithelial-derived alarmins, the hematopoie-
tic-derived cytokines are involved during both early and late
stages of infection, making it difficult to distinguish between
their effects on transmission, induction, and expulsion.
Nevertheless, IL-13 is by all accounts the most pivotal, being
required for protection against most parasitic nematodes,60–63
perhaps for its role in supporting the migration of dendritic
cells that subsequently drive adaptive immunity.64,65 IL-13 is
also critical for inducing many of the expulsion mechanisms in
the intestine that will be discussed further on. Although IL-4,
IL-5, IL-9, and IL-13 have distinct functions, there is
considerable redundancy between them. For instance, although
IL-4 deficiency strongly affects the expulsion of T. spiralis in
C57BL/6 mice, BALB/c mice are not affected by the lack of this
cytokine, whereas IL-13 deficiency is equally debilitating in
both strains.63 Similarly, female mice are resistant to T. muris
infection in the absence of IL-4 (in contrast to their male
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counterparts) mostly because of a stronger propensity for IL-13
production.66 Furthermore, with the exception of IL-4 in the
skin,67 IL-4 appears to be dispensable for N. brasiliensis
expulsion.61,68 The redundancy between IL-4 and IL-13 likely
stems from their shared usage of the IL-4Ra subunit,69–71
although interestingly, IL-4Ra deficiency in T cells has no
impact on worm expulsion during either T. spiralis,72
H. polygyrus,73 or N. brasiliensis61,62 infections, in contrast
to total IL-4Ra ablation.63,73–75 Instead, IL-4 might need to be
produced rather than recognized by T cells, as it is mostly
secreted by follicular helper T cells to promote IgG1 class
switching of B cells.68Nonetheless, IL-4 production by ILC2has
recently been implicated in the generation of protective T cell
immunity to H. polygyrus, and interestingly was dependent on
leukotriene D4.76 Leukotriene D4 did not induce IL-13 or IL-5
expression that as mentioned is mainly promoted by IL-25 and
IL-33, illustrating a compartmentalized activation mechanism.
IL-4 is also produced by basophils68,77,78 that also is more likely
to be important for humoral immunity and thus play a role
during challenge infections.
IL-5 has a complicated and context-dependent role in type 2
immunity. As with IL-13, it is secreted mainly by ILC2, but
functions predominantly as an eosinophil recruitment and
growth factor.79–81 Eosinophils, which make up only a fraction
of circulating leukocytes, are relatively abundant in the
intestinal tract82 and have traditionally been associated with
combating parasites. There are little data, however, to suggest
that deficiency in either IL-5 or eosinophils affects the
polarization of protective immunity or by extension the
outcome of infection, despite that eosinophil-derived media-
tors can skew dendritic cells to promote type 2 immunity.83,84
Thus, eosinophils do not appear to be critical for the generation
of T helper cell type 2 (Th2) immunity or clearance of
T. muris,85 and blocking IL-5 does not affect H. polygyrus
expulsion despite significantly decreasing eosinophil num-
bers.86 If anything, eosinophils act positively on the fecundity of
H. polygyrus worms.87 However, mice that overexpress IL-5
have massive systemic eosinophilia and are less susceptible to
N. brasiliensis,88 whereas eosinophil-deficient mice are unim-
paired in their ability to expel,89 illustrating that IL-5 has
additional unknown functions beyond those associated with
eosinophils.
As with the role of IL-5 in promoting eosinophil responses,
IL-9 acts mainly as a maturation factor for mucosal mast
cells,90–92 and is largely T cell derived,93–95 although it can be
secreted by ILC2,96 as well as by mast cells themselves97,98 that
in turn promote enhanced secretion of IL-25, IL-33, and TSLP
from epithelial cells.99 As a result, T. muris and H. polygyrus
expulsion are impaired in mast cell-deficient mice99,100 as well
as upon administration of neutralizing IL-9 antibodies,101,102
although it should be noted that studies using mast cell-
deficientmice (c-kitmutants) suffer frompossible confounding
factors given the role for c-kit onmany other cell types, and thus
remain to be clarified. Interestingly, a recent study also found
that mast cells not only can respond to IL-33 but might also
enhance the transmission of type 2 signals by the production of
IL-33 in response to adenosine triphosphate release by dying
epithelial cells.44
INDUCTION
Once the innate immune system has been alerted to the
presence of intestinal parasites, it must propagate the signal to
the mesenteric lymph nodes and engage the adaptive immune
system, a task mainly accomplished by conventional dendritic
cells (Figure 1b). Intestinal dendritic cells can be classified into
at least three distinct subsets based on their sole or combined
expression of CD11b and CD103, as well as the dependence on
either interferon regulatory factor 4 or 8 (IRF4 or IRF8) for their
development and/or survival.103 All three subsets are capable of
processing antigens, migrating to mesenteric lymph nodes
upon activation, and priming naive T cells.103 However, recent
evidence across various infection and allergy models demon-
strates a dominant role for IRF4-dependent CD11bþ dendritic
cells in the induction of Th2 immunity,52,104–111 notably during
infection with N. brasiliensis,104,105 T. muris,106,107 and the
parasitic trematode Schistosomamansoni.106,108,109 Conversely,
IRF8-dependent CD103þ dendritic cells are important for the
generation of type 1 responses of both helper112,113 and
cytotoxic114,115 T cells, thus promoting T. muris113 and H.
polygyrus116 chronicity. Together, these studies demonstrate
that specialized subsets of dendritic cells are responsible for
the induction of distinct types of adaptive immunity. Although
the precise mechanisms behind this compartmentalization are
unclear, they likely involve both cell-intrinsic signals and
external factors that actively promote the generation of
protective immunity and vice versa. One such example is
the phosphatase SHIP-1 that, if specifically deleted from
dendritic cells, results in impaired T. muris expulsion, likely
because of enhanced production of IL-12.117 Similarly, the
expression of CD40,118 OX40 ligand,119 and nuclear factor-
kB120 have all been implicated in the ability of dendritic cells to
generate optimal Th2 immunity in response to S. mansoni egg-
derived antigens, suggesting that levels of costimulation might
be a critical factor in determining the outcome of priming. In
contrast, expression of the transforming growth factor-b-
activating integrin avb8 promotes chronicity, with mice
becoming resistant to T. muris infection when avb8 is lacking
on dendritic cells.121 Similarly, the MAP3 (mitogen-activated
protein kinase kinase kinase) kinase TPL-2 was also shown to
modulate immunity toH. polygyrus, as its deletion in dendritic
cells resulted in enhanced resistance to infection that was
attributed to its downstream influence on the homing of
leukocytes.122 Indeed, different dendritic cell subsets have
divergent expression of certain cytokine and pattern-recogni-
tion receptors,123–126 and might thus be inherently more or less
prone to respond to specific pathogens and cytokines to begin
with. These types of signals, in combination with cell-extrinsic
cues from epithelial and innate immune cells, could determine
which type of dendritic cell that gets activated upon parasite
infection. Moreover, the nature of the initial stimulus is also
likely to have an impact on the resulting response.127 For
instance, dendritic cells in the skin of mice that are exposed to
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N. brasiliensis larvae or the contact sensitizer dibutyl phthalate
(both of which induce type 2 immunity) acquire distinct
transcriptional profiles, revealing a previously unappreciated
role for type I interferons during parasite infection,128 and
highlighting the complicated nature of pathogen recognition by
the innate immune system.
Interestingly, some studies suggest that ILC,129–131 baso-
phils,132–134 and eosinophils135,136 can express major histo-
compatibility complex class II and directly prime Th2
responses, notably upon N. brasiliensis131 and T. muris132
infections, with each cell type having been shown to migrate to
the mesenteric lymph nodes during infection.85,87,137,138
However, given that protective immunity is abolished in mice
where all139,140 or specific subsets104–106,108,109 of dendritic
cells have been depleted, it is perhaps more likely that these
other innate cells contribute to local tissue immunity by
promoting dendritic cell activation, or by further enhancing the
cytokine response of mature T cells that have migrated to the
infected tissue.53 Moreover, dendritic cells are responsive not
only to cytokines produced by other innate cells, but also
to epithelium-derived cytokines, including TSLP,54,141–143
IL-25,144 and IL-33,52,145 thus potentially bypassing ILC2
and granulocytes entirely.
The induction of adaptive immunity is paramount for
protection against gastrointestinal nematodes, with T cells no
doubt playing a critical role in worm expulsion, as is evident in
athymic or lymphopenicmice infected with T. spiralis,146,147N.
brasiliensis,148,149 T. muris150,151 and H. polygyrus.149,152
Immunity is mediated by helper T cells rather than cytotoxic
T cells, as shown by the neutralization of CD4þ but not CD8þ
cells153,154 and by adoptive transfer of CD4þ T cells from
previously infected mice that confers protection in normally
susceptible lymphopenic mice.155,156 In contrast, the role of B
cells in the immune response to nematode infection is more
context dependent. For instance, mice that lack mature B cells
appear to have less efficient expulsion of T. muris.157 However,
adoptive transfer of B cells alone from previously infected mice
is insufficient to confer resistance to T. muris infection,158
whereas transfer of IgA159 or IgG1 (refs. 160, 161) antibodies
from resistant mice confers partial resistance to various
nematodes, most likely because of their neutralizing effect
on secreted parasite antigens, or by trapping larvae.162–165
Given that adoptive transfer of helper T cells from previously
infected mice to lymphopenic mice can confer resistance,
these findings suggest that B cells might play a role in
promoting the generation and/or polarization of the T-cell
response, either by cytokine secretion or antigen presenta-
tion166,167 rather than directly affecting worm expulsion.
Antibodies might instead play a role upon secondary challenge,
if not during primary infections, as was shown for
H. polygyrus.165,168
Resistance to intestinal nematode infections is clearly
dependent on the induction of adaptive immunity, particularly
T cells. However, some data suggest that T cell-derived IL-4 and
IL-13 are dispensable for parasite expulsion, at least in the case
of N. brasiliensis infection,38,169 and can be provided by innate
sources instead. T cells might on the other hand be the more
important source of IL-9. As such, Th9 cells have been
suggested to be distinct from Th2 cells and mediate expulsion
ofN. brasiliensis95 and T. spiralis.39 Given that T cells represent
a much larger pool of effector cells in most infectious
contexts, and can respond in a similar way to innate cells
the relative importance of innate and adaptive immunity
remains to be established. It is also worth emphasizing that
these questions relate to primary infections only, most often
given as a large bolus of infectious stages. It must be
remembered that naturally occurring infections by these
parasites will be through repeated challenge with low numbers
of eggs or larvae throughout life, and thismaywell influence the
dynamics of the host response and the relative contributions of
the different immune components to the partial resistance that
is usually generated.
EXPULSION
Once adaptive immunity has been induced in the local lymph
nodes, activated effector cells must home back to the site of
infection where expulsion can take place. Ejection of gastro-
intestinal nematodes relies on a combination of physiological
mechanisms that include enhanced mucus secretion by goblet
cells, release of neutralizing proteins by granulocytes and
epithelial cells, epithelial hyperproliferation, and increased
intestinal peristalsis (Figure 1c), perhaps themost important of
which is augmented production of mucins. Mucins trap worms
by impeding motility, and hence mice lacking mucin 2 (the
predominant glycoprotein of the mucus layer) are rendered
susceptible to T. muris infection and show delayed worm
expulsion,170 illustrating the importance of this barrier.
Nonetheless, T. muris and other nematode larvae are still
able to penetrate the mucus layer of mucin-proficient mice
upon infection, indicating that they have evolved strategies to
circumvent this barrier. Indeed, one of the main secreted
proteins of T. muris is a serine protease with the capacity to
degrade Muc 2.171 The type 2 immune response, however, acts
not only to increase goblet cell proliferation and mucus
production, but also by modifying existing mucins by
sulphation172 and switching to secretion of Muc5ac that is
resistant to degradation.171 In addition, the host can produce
serine-protease inhibitors that prevent further loss ofmucin 2.171
Consistent with these data, Muc5ac is only upregulated in
resistant mouse strains170 and Muc5ac-deficient mice have
impaired expulsion of T. muris,N. brasiliensis, and T. spiralis.173
Increased mucus production and the mucin switch are largely
driven by IL-13,173 IL-4,174 and IL-22,175 but the principle of
physical obstruction provided by mucus layers can also be
extended to othermucosal sites such as the lungswhere the lectin
surfactant protein-D, which acts as a lubricant, is needed for
optimal protection against the pulmonary stage ofN. brasiliensis
infection.176
Another expulsion mechanism is the release of various
proteins by activated granulocytes and epithelial cells, most of
which are toxic to parasites. The relative contribution of each
molecule is highly context dependent. For instance, although
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eosinophils release a plethora of proteins that are potent in
killing worms in vitro,177,178 eosinophils appear to be
dispensable during most worm infections given that eosino-
phil-deficient mice are resistant seemingly despite their thinner
mucus layer.179 Mast cells on the other hand contribute to
worm expulsion through the release of various proteases that
serve to loosen tight junctions between epithelial cells, thus
aiding in the shedding of embedded worms, notably during T.
spiralis infection.180–182 However, mast cells appear to be
unessential for the expulsion of N. brasiliensis infection,183–185
illustrating the context-specific nature of these responses.
Goblet cells also secrete several molecules in addition tomucins
that contribute to expulsion.186–188 Resistin-like molecule-b
(RELMb), in particular, prevents lumen-dwelling worms from
feeding by effectively coating their cuticle, thus hampering
growth as well as blocking motility and attachment to the host
epithelium.186,188 RELMb expression is highly increased in the
intestinal epithelium during several parasite infections186
(likely induced by ILC2) and is involved in the expulsion of
H. polygyrus.188 It might also be required for efficient expulsion
of N. brasiliensis, although the data are conflicting.188,189 In
contrast, there seems to be no role for RELMb in the expulsion
of T. spiralis or T. muris.187,188 RELMa, on the other hand, is
mainly expressed in the pulmonary epithelium and might be
important for combating the pulmonary stage of N. brasi-
liensis.189 RELMa is further implicated in the function of
alternatively activated macrophages, highlighting its role in
type 2 immune responses.
After being trapped in mucus and coated by various toxic
proteins and neutralizing antibodies, worms are expelled by a
combination of increased epithelial proliferation and intestinal
peristalsis. The precise contribution of each mechanism likely
depends on the parasite in question. For instance, accelerated
epithelial turnover might bemore important for expulsion ofT.
muris worms that preferentially infect epithelial cells. Because
of its rapid turnover,T. murisworms thus need to continuously
burrow through the epithelium in order to remain within their
niche. Accordingly, epithelial hyperproliferation serves to shift
the epithelium outward from the crypts. In contrast, peristalsis
might be ofmore relevance duringH. polygyrus infection, given
that the worms enter the lamina propria and resurface to wrap
around the villi rather than specifically infecting the epithelium,
as is the case for T. muris. Peristalsis could therefore aid in
shedding infected cells that the parasite is attached to. Increased
epithelial turnover in response to T. muris infection seems to
occur mainly in resistant mouse strains, largely driven by
IL-13,190 and as such, signaling pathways that regulate the
proliferation of epithelial stem cells such as the lysine
methyltransferase Setd7 affect the outcome of T. muris
infection, but notH. polygyrus infection.191 Intestinal peristalsis
is mediated by contraction of smooth muscle cells, and is
induced by both IL-9 (ref. 102), IL-4 and IL-13,27,73,192 and
seems to be controlled mainly by T cells. Thus, the respon-
siveness of smooth muscle cells to neurotransmitters that
control contraction via muscarinic receptors are important for
N. brasiliensis expulsion.193 Most of the available data on gut
peristalsis during nematode infection are however highly
correlative73,102 and its importance remains to be established.
Nevertheless, together these mechanisms effectively expel the
invading parasite.
RESOLUTION
When a worm infection has been cleared, inflammation is
resolved and the damaged tissuemust be repaired. This process
is partly orchestrated by type 2 cytokines and involves several
cell types, notably macrophages and eosinophils (Figure 1c).
Thus, despite being redundant for the expulsion of most
nematodes, eosinophils might be important for wound healing
and tissue regeneration in which they have been implicated in
nonmucosal tissues.194–196 Eosinophils have also been shown to
promote the survival of long-lived plasma cells in the bone
marrow197 as well as the generation of IgA-secreting plasma
cells in the gastrointestinal tract179,198 (at least in the small
intestine199) via the production of IL-1b, suggesting that they
might affect secondary challenge infections where antibodies
presumably play a larger role. Indeed, both IL-5 and eosinophil-
deficient mice harbor increased numbers of N. brasiliensis
larvae after secondary infection,89 with similar results during
secondary T. spiralis infection.200 Furthermore, eosinophils
negatively regulate Th17 cells201 and promote the expansion of
regulatory T cells in the steady state198,202 that might affect
overall inflammation, illustrating their complex contribution to
tissue homeostasis. Similarly, whereas resident intestinal
macrophages are mostly suppressive in nature and do not
act inflammatory to pathogen stimulation, type 2 cytokines give
rise to alternatively activated macrophages that might con-
tribute to the expulsion of certain parasites.75,192,203,204
Furthermore, macrophages in the intestinal mucosa are also
likely to play an important role in tissue repair, as has been
shown in various settings of inflammation.205–210
Whereas most research on host–parasite interactions has
focused on the underlying factors that govern resistance and
susceptibility, the long-term consequences of both acute and
chronic worm infections are largely unexplored. Given the
inverse correlation between parasite exposure and the occur-
rence of immune-associated disorders, it is quite surprising that
so little attention has been devoted to this subject, particularly
in the case of Trichuris infections that have been in clinical trial
for the treatment of various inflammatory disorders.9,211
Chronically infected mice do not display any overt symptoms
of disease, but are by no means unaffected considering that
persistent T. muris infections are lethal in the absence of
IL-10,212 indicating that there is ongoing inflammation beyond
the spontaneous inflammation inherent to il10–/– mice. Indeed,
chronic T. muris infection results in the accumulation of
interferon-gþ T cells in the bone marrow,213 and does not
appear to protect against the development of colitis.214,215
Furthermore, depending on the strain, chronically infected
mice gain less weight than their uninfected counterparts,216 and
in some cases even acquire colitis-like symptoms, thus losing
weight,217 mirroring the malnutrition and wasting of some
infected humans. In contrast, lung pathology appears to be
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decreased in response to papain challenge,218 illustrating that
worm-induced protection against inflammatory disorders is
highly context specific. Data on the long-term effects of acuteT.
muris infection are even sparser. Alternatively activated
macrophages seem to increase in number after expulsion,219
perhaps contributing to tissue repair, and there are dramatic
changes to the epithelial niche, with increased numbers of
mucosal mast cells that persist in the epithelium for months
after expulsion and appear to affect epithelial barrier integ-
rity.220 However, other potential long-lasting consequences of
acute T. muris infection remain unexplored. In contrast, H.
polygyrus appears to be protective in several inflammatory
models,221,222 and this has been attributed to its ability to
dampen inflammation by promoting the generation and
function of regulatory T cells via some of its secreted
proteins.223,224 Hence, the hygiene hypothesis might apply
only to a narrow group of nematodes and it is important that we
distinguish between general phenomena of parasite infection
(such as the importance of IL-13) and more specific ones (such
as the contribution of eosinophils) if we are to apply our
knowledge to patients in the clinic.
CONCLUSIONS AND FUTURE CHALLENGES
Parasitic nematodes are an integral part of the mucosal milieu
and have played an important role in the evolution of the
intestinal immune system. Their presence leads to the
induction of type 2 immunity that involves a vast array of
cell types and molecules that work in concert to protect against
a wide range of extracellular parasites at mucosal surfaces.
Although some worm infections might be beneficial to human
health, the long-term effects of infection remain poorly
understood and there are many unresolved questions as
follows. (i) To what extent are parasites able to directly
manipulate the immune system, and with what consequences
on subsequent infections? Nematodes clearly have the ability to
influence the host as they are often able to survive for extended
periods of time without causing pronounced inflammation.
Identifying the pathways that are regulated upon infection thus
might prove valuable for the development of new anti-
inflammatory drugs. (ii) How does early parasite exposure
affect the developing immune system? Given that nematode
infections mainly afflict children it is not unlikely that their
immune system is permanently altered as a consequence. (iii)
What is the contribution of the microbiota in regulating
immune responses to extracellular parasites? Some, or even
many of the observed effects on the host upon nematode
infection might be due to changes in bacterial composition.
Establishing the causal links in the cross-talk between intestinal
bacteria, parasites, and the immune system is notoriously
difficult and remains to be resolved. (iv) Can parasite-derived
molecules be harnessed for treating immune-associated dis-
orders, and are they sufficient? Answering these and other
questions will be important as more and more people are
afflicted with various diseases partly attributed to the absence of
nematode infections.
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